On today's episode I speak with Noor Siddiqui, the founder of Orchid, a company that quantifies the genetic risks of your future children. We discuss the plunge in genome sequencing costs and why Orchid's ability to predict polygenic diseases impacts so many families compared to predicting single-gene diseases.
Noor reveals what it was like starting a company remotely during COVID, how her mother's own rare disease motivated her and what genetic privilege means. We discuss her path from doing a Thiel fellowship to teaching a crypto class at Stanford to doing genomics and AI research with Sebastian Thrun. Finally, we get into our contrarian views and why biology advances seem to provoke the strongest pushback.
Full transcript on Medium. This episode was produced by Daniel Bouza.